Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.

Fibromyalgia position paper / Sarzi-Puttini, Piercarlo; Giorgi, Valeria; Atzeni, Fabiola; Gorla, Roberto; Kosek, Eva; Choy, Ernest H; Bazzichi, Laura; Hauser, Winfred; Ablin, Jacob N; Aloush, Valerie; Buskila, Dan; Amital, Howard; Da Silva, Jose A P; Perrot, Serge; Morlion, Bart; Polati, Enrico; Schweiger, Vittorio; Coaccioli, Stefano; Varrassi, Giustino; Di Franco, Manuela; Torta, Riccardo; Øien Forseth, Karin Maria; Mannerkorpi, Kaisa; Salaffi, Fausto; Di Carlo, Marco; Cassisi, Gianniantonio; Batticciotto, Alberto. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - STAMPA. - (2021).

Fibromyalgia position paper

Salaffi, Fausto;Di Carlo, Marco;
2021-01-01

Abstract

Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.
2021
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/290327
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 42
  • ???jsp.display-item.citation.isi??? ND
social impact